FDA — authorised 12 April 2000
- Marketing authorisation holder: VALEANT LUXEMBOURG
- Status: approved
FDA authorised Visudyne on 12 April 2000
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 12 April 2000; FDA authorised it on 22 August 2001.
VALEANT LUXEMBOURG holds the US marketing authorisation.